Edwards Lifesciences (EW) EPS (Weighted Average and Diluted) (2009 - 2026)
Edwards Lifesciences (EW) recorded quarterly EPS (Weighted Average and Diluted) of $0.66 in Q1 2026, up 500.0% quarter-over-quarter from $0.11 in Q4 2025, and up 8.2% on a YoY basis from $0.61 in Q1 2025.
Edwards Lifesciences (EW) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Edwards Lifesciences' EPS (Weighted Average and Diluted) history runs 18 years deep, the most recent figure standing at $0.66 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 8.2% year-over-year to $0.66; the TTM figure through Mar 2026 stood at $1.83 (down 73.86% YoY), while the FY2025 annual figure was $1.81, down 22.65% from the prior year.
- EPS (Weighted Average and Diluted) was $0.66 for Q1 2026 at Edwards Lifesciences, up from $0.11 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $5.13 in Q3 2024 to a low of $0.11 in Q4 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.82 across 5 years, with a median of $0.59 in 2022.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) jumped 832.73% in 2024, then plunged 90.25% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.65 in 2022, then slipped by 6.15% to $0.61 in 2023, then advanced by 6.56% to $0.65 in 2024, then sank by 83.08% to $0.11 in 2025, then surged by 500.0% to $0.66 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.66 (Q1 2026), $0.11 (Q4 2025), and $0.5 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.66 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.85 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 0.51 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 2.24 |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 0.50 |
| Jun 30, 2025 | 0.56 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 5.13 |
| Jun 30, 2024 | 0.61 |
| Mar 31, 2024 | 0.58 |
| Dec 31, 2023 | 0.61 |
| Sep 30, 2023 | 0.55 |
| Jun 30, 2023 | 0.50 |
| Mar 31, 2023 | 0.49 |
| Dec 31, 2022 | 0.65 |
| Sep 30, 2022 | 0.55 |
| Jun 30, 2022 | 0.65 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.53 |
| Sep 30, 2021 | 0.54 |
| Jun 30, 2021 | 0.78 |